Rhode Island H7925 allows personal cultivation of psilocybin for personal use and mandates health department rules contingent on FDA actions.
Rhode Island H7925 amends the state's controlled substances law to permit individuals to cultivate psilocybin within their residence for personal use. This change is contingent on the Food and Drug Administration (FDA) rescheduling psilocybin. If the FDA reschedules psilocybin, the Rhode Island Department of Health must establish rules and regulations for its cultivation, distribution, and medical prescription.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.